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In the skin, the lack of markers permitting the unam-
biguous identification of macrophages and of con-
ventional and monocyte-derived dendritic cells
(DCs) complicates understanding of their contribu-
tion to skin integrity and to immune responses. By
combining CD64 and CCR2 staining, we successfully
identified each of these cell types and studied their
origin, transcriptomic signatures, and migratory and
T cell stimulatory properties. We also analyzed the
impact of microbiota on their development and their
contribution to skin inflammation during contact hy-
persensitivity. Dermal macrophages had a unique
scavenging role and were unable tomigrate and acti-
vate T cells. Conventional dermal DCs excelled both
at migrating and activating T cells. In the steady-
state dermis, monocyte-derived DCs are continu-
ously generated by extravasated Ly-6Chi monocytes.
Their T cell stimulatory capacity combined with their
poor migratory ability made them particularly suited
to activate skin-tropic T cells. Therefore, a high de-
gree of functional specialization occurs among the
mononuclear phagocytes of the skin.
INTRODUCTION
Langerhans cells (LCs), the only dendritic cells (DCs) of the
epidermis, were originally considered the principle antigen-pre-
senting cells (APCs) of the skin. However, recent studies have
demonstrated that the dermis contains a dense network of
DCs. Five distinct DC subsets—including LCs in transit to the
skin-draining lymph nodes (LNs)—have been identified in
steady-state mouse dermis (Henri et al., 2010). Among them,
CD11b+ dermal DCs have a phenotype that overlaps with thatIof dermal macrophages, complicating their identification and
the assessment of their function (Haniffa et al., 2012; Hashimoto
et al., 2011; Henri et al., 2010).
In the adult, conventional DCs are continuously renewed by
bone-marrow (BM)-derived blood-borne progenitors known as
pre-DCs and have a unique dependence for the Fms-like tyro-
sine kinase receptor 3 ligand (Flt3L) (Liu et al., 2007). In contrast
to dermal DCs, LCs develop from embryonic macrophages that
are recruited in the epidermis during embryonic life (Chorro et al.,
2009; Hoeffel et al., 2012). Some macrophages including liver
Kuppfer cells and the brain microglia are also established prior
to birth and maintain themselves without further input from adult
hematopoiesis (Ginhoux et al., 2010; Kierdorf et al., 2013; Schulz
et al., 2012). In contrast, the macrophages residing in the intes-
tinal lamina propria (LP) are continuously renewed from blood
Ly-6Chi monocytes (Varol et al., 2009). Recent studies showed
that the macrophages found in the lung and kidney have a dual
origin involving both embryonic and adult hematopoiesis (Schulz
et al., 2012). The exact origin of dermal macrophages remains to
be determined, however.
Conventional DCs induce T cell responses against invading
pathogens. This key role relies on their ability to capture and
display antigens in the context of major histocompatibility com-
plex (MHC) class I and II molecules and to migrate to tissue-
draining LNs where they activate antigen-specific naive
T cells. In contrast, macrophages primarily reside in tissues
where they scavenge damaged cells or invading bacteria, pro-
duce anti-inflammatory cytokines, and promote tissue repair
(Hashimoto et al., 2011). However, because of their overlapping
phenotypes, it is difficult to distinguish DCs and macrophages
within most tissues and evaluate their exact contribution to im-
mune responses.
The Immunological Genome (ImmGen) Project has recently
provided a comparative analysis of the subsets of DCs, mono-
cytes, and macrophages found in the mouse (Gautier et al.,
2012; Miller et al., 2012). The CD11b+ cells found in tissues
such as the dermis have been, however, excluded from the
ImmGen analysis because they constitute an unresolvedmmunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc. 925
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Resolving Skin Mononuclear Phagocyte Complexitymixture of cells of different developmental origin (Hashimoto
et al., 2011; Henri et al., 2010). Here, we have demonstrated
that, under both steady-state and inflammatory conditions,
CD11b+ dermal DCs can be readily distinguished from dermal
macrophages based on a small constellation of surface
markers. In addition, we have shown that the steady-state
dermis contains an extravascular pool of Ly-6Chi monocytes
that continuously generate monocyte-derived DCs (moDCs).
On the basis of these findings, we determined the gene-expres-
sion profiles of the monocytes, moDCs, macrophages, and
CD11b+ DCs found in the steady-state dermis, leading to the
determination of the defining features of these various dermal
cell types. Finally, we investigated these populations for their
T cell-stimulatory properties, phagocytic activity, and role in
contact hypersensitivity (CHS), an experimental model for
human allergic contact dermatitis.
RESULTS
CD11b+ Dermal Cells Have at Least Two Distinct Origins
The CD11b+CD24lo dermal cells (called CD11b+ dermal cells;
Figure 1A; see also Figure S1A available online) are heteroge-
neous and likely at least composed of DCs and of macrophages
(Haniffa et al., 2012; Henri et al., 2010). The expression of CD64,
the high-affinity IgG receptor FcgRI, discriminates CD64– DCs
from CD64lo to hi non-DCs among the CD11b+ cells found in
the intestine, the muscle, and the spleen (Bain et al., 2013;
Gautier et al., 2012; Langlet et al., 2012; Tamoutounour et al.,
2012). By combining CD64 and Ly-6C expression, CD11b+
dermal cells can also be separated into a homogeneous
Ly-6C–CD64– subset and in cells that can be included
into a Ly-6Clo to hiCD64lo to hi gate (Figure 1A). In contrast to
Ly-6Clo to hiCD64lo to hi cells, Ly-6C–CD64– cells were markedly
reduced in mice lacking Flt3L (Figure S1B). Mice deficient in
CCR2 showed reduced numbers of Ly-6Chi blood monocytes
and normal numbers of DCs (Serbina and Pamer, 2006). To
determine whether the Ly-6C–CD64– and Ly-6Clo to hi
CD64lo to hi dermal cells were differentially affected by CCR2
deficiency, we lethally irradiated mice coexpressing CD45.1
and CD45.2 and reconstituted them with a 1 to 1 mixture of BM
cells isolated from wild-type (WT) CD45.1+ B6 mice and from
CD45.2+ B6 mice that lacked CCR2. Those chimeras, called B6
(CD45.1) WT + B6 (CD45.2) Ccr2–/–/ B6 (CD45.1–CD45.2) chi-
meras, were analyzed 8 weeks after BM transfer. As expected,
90%of the Ly-6Chi bloodmonocytes were CD45.1+ and thus pri-
marily derived from CCR2+ cells (data not shown). Eighty-five
percent of the Ly-6Clo to hiCD64lo to hi dermal cells were
CD45.1+, leading to a high CD45.1/CD45.2 ratio (Figure S1C).
In contrast, Ly-6C–CD64– cells showed a lowCD45.1/CD45.2 ra-
tio similar to those of conventional CD8a+-type dermal DCs (Fig-
ure S1C; data not shown). Therefore, the CD11b+ dermal cells
were heterogeneous in terms of Flt3L- and CCR2-dependency.
The specific absence of Ly-6C–CD64– cells in Flt3L-deficient
mice combined with their capacity to develop in a CCR2-inde-
pendent manner demonstrated that they corresponded to con-
ventional DCs. Accordingly, they were subsequently called
CD11b+ dermal DCs. In contrast, the Ly-6Clo to hiCD64lo to hi cells
were Flt3L-independent and CCR2-dependent and were called
‘‘CD11b+ non-DCs.’’926 Immunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc.Dermal CD11b+ non-DCs Are Heterogeneous
The dermal CD11b+ non-DCs comprised a CCR2+CD64lo to +
(denoted as CCR2+) and a CCR2 to loCD64hi (denoted as
CCR2–) subset (Figure 1A). On a Ly-6C-MHCII dot plot, the
CCR2+ subset consisted of Ly-6ChiMHCII–, Ly-6Chi to intMHCII+,
and Ly-6C
lo
MHCII+ cells, called population 1 (P1), P2, and P3,
respectively (Figure 1A). A similar CCR2+ cell subset was found
in the LP of steady-state intestine and it also showed a
waterfall-shaped distribution on a Ly-6C-MHCII dot plot (Fig-
ure S1D). In the case of the LP, P1 cells were shown to corre-
spond to recently extravasated Ly-6Chi blood monocytes that
continuously differentiate into P3 cells via P2 intermediates
(Bain et al., 2013; Tamoutounour et al., 2012). The CCR2– subset
of CD11b+ non-DCs found in the dermis segregated into Ly-
6CloMHCII– and Ly-6CloMHCII+ cells that were denoted as P4
and P5, respectively (Figure 1A). The dermis of neonates mainly
contained P4 cells (data not shown), suggesting that part of the
MHCII– P4 cells can subsequently mature into MHCII+ P5 cells.
The composition of the CCR2– subset found in the LP of
steady-state intestine of adult mice differed from that of the
dermis and was dominated by ‘‘mature’’ P5 cells (Figure S1D),
that corresponded to CX3CR1
hi macrophages (data not shown).
Analysis of cytospin preparation after Wright-Giemsa staining
showed that the CD11b+ dermal DCs had a typical DC
morphology with numerous small lamellipodia whereas the P1
dermal cells resembled blood monocytes (Figure 1B). Both P2
and P3 dermal cells had an intermediate morphology between
DCs and macrophages, whereas P4 and P5 cells had typical
features of tissue macrophages (Bain et al., 2013), being large
with abundant foamy cytoplasm and prominent cytoplasmic
vacuoles and resembling the CD1a–CD14+FXIIIa+ macrophages
found in human dermis (Haniffa et al., 2009).
Coexpression of CD64 andMerTK, a receptor protein-tyrosine
kinase that recognizes apoptotic cells, can be used for identifica-
tion of tissue macrophages as recently demonstrated for the
lung (Gautier et al., 2012). Analysis of P1–P3 CCR2+ dermal cells
on a CD64-MerTK dot plot showed that they were CD64lo to +
MerTK– to lo, whereas CCR2– P4 and P5 dermal cells were
CD64hiMerTK+ (Figures 1C and 1D). P4 and P5 cells were thus
the only CD11b+ dermal cells to express CD64 and MerTK in
amounts expected for tissue macrophages (Gautier et al.,
2012). Therefore, based on CCR2 versus Flt3L dependency, on
differential CCR2, CD64, and MerTK expression, and on
morphological criteria, the heterogeneous CD11b+ cells found
in the steady-state dermis could be resolved into CD11b+ DCs,
macrophages (P4 and P5 cells), and, as substantiated below,
into monocyte-derived P1, P2, and P3 cells (Table 1). Impor-
tantly, analysis of P1, P2, P3, P4, and P5 cells and of CD11b+
DCs for CX3CR1, F4/80, CD68 and lysozyme M expression
showed that in the dermis these molecules cannot be used to
distinguish macrophages and P1, P2, and P3 cells from
CD11b+ DCs (Figure S1E).
Principal Component Analysis Establishes the Genetic
Relatedness of CD11b+ Dermal Cell Subsets
To determine the diversity in gene expression among the six
distinguishable CD11b+ dermal cell subsets and assess their
genetic relatedness, we sorted them in triplicates and subjected
them to gene-expression profiling (Table S1). Ly-6Chi blood
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Figure 1. Characterization of CD11b+ Dermal Cells
(A) Single-cell suspensions were prepared by enzymatic digestion and gentle dissociation of ear skin. After excluding dead cells, T cells, NK cells, B cells, and
neutrophils, the remaining CD45.2+ cells were analyzed by cytofluorometry for the expression of CD24 and CD11b. CD11b+CD24lo cells were further analyzed for
Ly-6C versus CD64 expression. After excluding Ly-6C–CD64– CD11b+ dermal DCs, the remaining CD11b+ non-DC fraction (made of Ly-6Clo to hiCD64lo to hi cells)
was analyzed for the expression of CCR2 and CD64 and subdivided into a CCR2+CD64lo to + (denoted as CCR2+) and a CCR2 to loCD64hi (denoted as CCR2–)
subset. Finally, the CCR2+ and CCR2– subsets were analyzed for the expression of Ly-6C and MHCII allowing to distinguish among them three (P1, P2, and P3)
and two (P4 and P5) populations, respectively. The percentages of cells found in each of the specified gates are indicated.
(B) Morphological characteristics of CD11b+ DCs and of P1 to P5 cells sorted from steady-state dermis and analyzed by Wright-Giemsa staining after cytospin
onto glass slides. Three representative cells are shown for each population. Panels P2, P4, and P5 are made of two to three concatenated images. Scale bars
represent 10 mM.
(C) Analysis of CCR2+ and CCR2–cells for MerTK and CD64 expression.
(D) Among CD11b+ non-DCs, the CD64lo to +MerTK– to lo and CD64hiMerTK+ correspond to CCR2+ (P1-P3) and CCR2– (P4-P5) cells, respectively. The per-
centages of cells found in each of the specified gates are indicated. Data in (A)–(D) are representative of three independent experiments. See also Figure S1 and
Table S1.
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Resolving Skin Mononuclear Phagocyte Complexitymonocytes were also included to determine whether they
showed a closer relation to dermal P1 cells, their putative direct
progeny, than to the other analyzed subsets. Principal compo-
nent analysis (PCA) showed a close proximity of triplicates (Fig-Iure 2A). Differences between Ly-6Chi blood monocytes and all
the other dermal cell populations accounted for the major
component of the overall variability observed in the data set
(PC1 axis in Figure 2A). This is consistent with other observationsmmunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc. 927
Table 1. Phenotype and Frequency of CD11b+ DCs, Monocytes, moDCs, and Macrophages in Steady-State Mouse Dermis
CD11b+ Dermal Subset Phenotype Frequency (%)
CD11b+ DCs CD11b+, CD64, MerTK, CCR2+, Ly-6C MHCII+, CD11clo to +, CD24lo 52.2 ± 6.2
P1 dermal monocytes CD11b+, CD64lo, MerTK to lo, CCR2+, Ly-6Chi, MHCII, CD11c, CD24 4.4 ± 1.5
P2 moDCs CD11b+, CD64lo, MerTK to lo, CCR2+, Ly-6Chi, MHCII lo, CD11c to lo, CD24 5.5 ± 1.7
P3 moDCs CD11b+, CD64+, MerTK to lo, CCR2+, Ly-6C lo, MHCII+, CD11c to lo, CD24 5.0 ± 1.9
P4 dermal macrophages CD11b+, CD64hi, MerTK+, CCR2lo, Ly-6Clo, MHCII, CD11c, CD24 3.6 ± 0.7
P5 dermal macrophages CD11b+, CD64hi, MerTK+, CCR2lo, Ly-6Clo, MHCII+, CD11c to lo, CD24 7.1 ± 4.0
In addition to the CD11b+CD24lo DCs, the skin dermis also contains CD11b+CD24+ LCs en route to the draining LNs, as well as CD11bCD24+ DCs.
and CD11bCD24lo DCs. The expression of CD24 coincides with that of CD207. Accordingly, we have used it in lieu of CD207 expression because it
required no prior cell permeabilization as needed for CD207.
The percentage and cell number ± SEM of each subset were calculated from five independent experiments. Cell subsets were defined as in Figure 1.
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Resolving Skin Mononuclear Phagocyte Complexitysuggesting that the gene-expression profile of DCs depends
in part on their anatomical site of residence (Elpek et al., 2011).
The genes that were highly expressed in all the dermis-resident
mononuclear phagocytic cells compared to Ly-6Chi blood
monocytes (gene cluster C1, Figure 3A and Table S2) were
enriched for annotations pertaining to skin development or
pathologies (Figure S2). Interestingly, analysis of all the CCR2+
subsets in a PC1-PC3 two-dimensional space showed that the
P1 and P2 cells ‘‘bridged’’ the positions occupied by the blood
Ly-6Chi monocytes and the P3 cells (Figure 2A), a feature
expected for developmental intermediates linking recently ex-
travasated Ly-6Chi monocytes to P3 cells. On the PC3 axis,
the opposite positions occupied by the CD11b+ DCs and the
P4-P5 macrophages (Figure 2A) supported their unique tran-
scriptomic signatures (gene clusters C3 and C5 in the case of
CD11b+ DCs and gene cluster C6 in the case of P4-P5 macro-
phages, Figures 3A and Table S2). Consistent with PCA, hierar-
chical clustering further showed that Ly-6Chi blood monocytes
and P1 dermal cells clustered together, apart from all other pop-
ulations and that P4 and P5 dermal macrophages clustered
away from the remaining populations (Figure 2B). Moreover, in
support of the transcriptomic signature shared between P2-P3
cells and CD11b+ dermal DCs (gene cluster C4, Figures 3A
and Table S2), P2 and P3 cells clustered together with CD11b+
dermal DCs.
Dermal CD11b+ DCs, moDCs, and Macrophages Show
Distinct Canonical Transcriptomic Signatures
A GeneSet Enrichment Analysis (GSEA) was used to compare
the expression of canonical transcriptomic signatures among
the six identified CD11b+ dermal cell subsets (Figure S3). The
GSEA confirmed that P1 cells closely resembled Ly-6Chi blood
monocytes in that both of themwere strongly enriched for signa-
ture corresponding to MHCII– and MHCIIint/– Ly-6Chi blood
monocytes and for an anti-correlated CD11b+ DC signature.
P4 and P5 macrophages were both highly enriched for a tissue
macrophage and a primitive macrophage signature and
counter-enriched for a signature corresponding tomacrophages
of adult origin. As expected, CD11b+ dermal DCs strongly
expressed the ‘‘DC’’ signature and were the lowest expressers
of the anticorrelated CD11b+ DC signature. P2 and P3 cells
were the strongest expressers of the signature corresponding
to MHCII– and MHCIIint/– Ly-6Chi blood monocytes, ranking
next to Ly-6Chi blood monocytes and P1 cells. Consistent with928 Immunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc.their grouping with CD11b+ dermal DCs (Figure 2B), P2 and P3
cells were the second strongest expressers of the ‘‘DC’’ signa-
ture after CD11b+ dermal DCs. Therefore, as suggested by hier-
archical clustering, some commonalities exist between the
gene-expression programs of P2 and P3 cells and of CD11b+
dermal DCs. Moreover, the variance among the gene-expres-
sion profiles and the GSEAwere fully consistent with our catego-
rization of dermal CD11b+ cells into CD11b+ dermal DCs and
dermal macrophages (P4 and P5). It is also congruent with the
view that a pool of extravascular Ly-6Chi monocytes (P1 cells)
exists in the steady-state dermis and gives rises to P2 and P3
cells that acquire transcriptomic features reminiscent of
CD11b+ DCs on the top of their monocytic signature.
P1, P2, and P3 Dermal Cells Are Organized in a
Developmental Series
To validate that a precursor-product relationship exists between
the P1, P2, and P3 cells, we analyzed their kinetics of reappear-
ance following diphtheria toxin (DT) treatment of CD11b-DTR
mice (Duffield et al., 2005). CD11b-DTR mice die after repeated
DT injections. This limitation was obviated by using CD11b-DTR
(CD45.2)/ B6 (CD45.1) BM chimeras. Eight weeks after recon-
stitution, chimeric mice were injected twice with DT 48 hr apart.
Within 5 hr after the last DT injection, more than 99% of the P1,
P2, and P3 cells were ablated (Figure 2C). At 12 hr after injection,
a few P1 cells were already present and P2 and P3 cells were re-
generated in sequence over the next 2 weeks. Twenty days after
DT treatment, the P1-P2-P3 ‘‘waterfall’’ showed a normal
composition. Therefore, these data support the notion of a
sequential P1 / P2 / P3 generation, akin to the situation
observed in the intestinal LP (Bain et al., 2013; Tamoutounour
et al., 2012). Considering that Ly-6Chi blood monocytes and P1
cells systematically clustered together in all our tests of genetic
variance (Figures 2; Figure S3) and showed an identical
morphology and surface phenotype (Figures 1A and 1B), it is
likely that the extravasated Ly-6Chi bloodmonocytes constituted
the direct precursors of the P1/P2/P3 developmental series
found in the dermis. Analysis of the dermis from mice sacrificed
5 min after being injected intravenously with fluorochrome-
conjugated antibodies specific for the pan-leukocyte marker
CD45 revealed that the P1 to P5 cells were all CD45–, whereas
100% of the Ly-6Chi blood monocytes were CD45+ (data not
shown). Therefore, the monocyte-derived P1, P2, and P3 cells
found in the steady-state dermis were extravascular.
Figure 2. Gene Expression among the Six CD11b+ Dermal Cell Subsets and Blood Ly-6Chi Monocytes and Origin of the CD11b+ non-DCs
Found in Steady-State Dermis
(A) Principal component analysis (PCA) of gene expression by the six CD11b+ dermal cell subsets and Ly-6Chi blood monocytes. Numbers in parentheses
indicate the percentage of overall variability of the data set along each PC axis. The PC1 axis accounted for 20% of the variability whereas the next two PC axes
accounted each for 10% of the variability. All the remaining PC axes accounted for less than 6% of the variability.
(B) Hierarchical clustering with average linkage was performed on the specified subsets to assess their transcriptional relatedness.
(C) B6 CD11b-DTR (CD45.2)/B6 (CD45.1) BM chimeras were left untreated or treated with DT. CD11b+CCR2+ non-DCs were analyzed for expression of Ly-6C
and MHCII expression at the specified time points. The percentages of cells found in each of the specified gates are indicated.
(D) Absolute number of the specified cell subsets in the dermis of B6 mice raised under SPF or GF conditions. *p < 0.05; **p < 0.01, unpaired Student’s t test.
(E) Expression of MerTK and CD64 on CD11b+ non-DCs from WT and Ccr2–/– mice.
(F) Percentages of the specified dermal CD11b+ cell subsets in the ear of B6 and Ccr2–/– mice. The surface of the pie charts is proportional to the absolute
numbers of CD11b+ cells per ear.
(G) Percentages of donor chimerism in Ly-6Chi blood monocytes, in monocytes (P1), moDCs (P2-P3), macrophages (P4-P5), and LCs from the skin of parabiotic
mice. Error bars correspond to the mean ± SD. Data in (A)–(D) are representative of three independent experiments. See also Figure S2.
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Resolving Skin Mononuclear Phagocyte ComplexityInterestingly, the P1 / P2 / P3 developmental series
unfolded in the dermis of germ-free (GF) mice but yielded P2
and P3 cells in numbers that were significantly decreased as
compared to mice kept under specific pathogen free (SPF) con-
ditions (Figure 2D). In contrast, normal numbers of P4 and P5
macrophages were found in adult GF mice, suggesting that the
postulated P4 to P5 maturation occurred irrespective of the
presence of microbiota (Figure 2D). Therefore, Ly-6Chi blood
monocytes enter the steady-state dermis independently of the
skin microflora, and, once in the dermis, lose Ly-6C and acquire
MHCII and CD64 expression and a gene signature that
converged in part with that of CD11b+ DCs (Figures 2 and 3).
Owing to these unique features and to their capacity to stimulate
naive T cells (see below), the P2 and P3 cells found in the steady-
state dermis were denoted as moDCs.
Dermal Macrophages Have Two Distinct Origins
We sought to characterize CD11b+ non-DCs in the dermis of
adult Ccr2–/– mice. In contrast to WT dermis that comprised
both P1-P3 (CD64lo to +MerTK– to lo) and P4-P5 (CD64hiMerTK+)
cells, the Ccr2–/– dermis was almost deprived of monocyte-
derived P1-P3 cells but contained P4-P5 macrophages, how-
ever, in numbers that represent only 20% that of WT mice
(Figures 2E and 2F). Therefore, the P4-P5 macrophages found
in the dermis of adult mice likely consist of a pool that is estab-
lished prenatally and persists in adult mice kept under SPF
conditions and of a pool that is absent in Ccr2–/– mice and is
generated frombloodmonocytes in aCCR2-dependent manner.
Consistent with that view, in B6 (CD45.1) WT + B6 (CD45.2)
Ccr2–/– / B6 (CD45.1-CD45.2) chimeras, precursors derived
from adult BM were capable of reconstituting CD64hiMerTK+
P4 and P5 macrophages in a CCR2-dependent manner (data
not shown). To eliminate the possibility that ablation of P4-P5
cells via irradiation might have triggered a nonphysiological
reconstitution process in the chimeras, we established parabi-
osis between mice expressing CD45.1 and CD45.2 (Figure 2G).
Analysis of mice that had shared their blood supply for 8 weeks
showed that T cells were evenly distributed in the blood of para-
bionts (data not shown). Moreover, LCs that self-renew without
input from blood precursors showed no exchange between part-
ners (Figure 2G). In contrast, Ly-6Chi blood monocytes, P1-P3
dermal cells, and P4-P5 dermal macrophages exchanged be-
tween partners with approximately 20% of the cells originating
from the parabiotic partner (Figure 2G). Such distribution be-
tween parabionts is reminiscent of that observed for lymphoid-
tissue resident DCs, the precursors of which do not spend
enough time in the circulation to equilibrate between parabionts,
leading to percentages of chimerism in the 17% to 36% range
(Liu et al., 2007). Consistent with their expected precursor-
product relationship, the degree of chimerism achieved by the
P1-P3 cells found in the dermis was identical to that of the Ly-
6Chi blood monocytes (Figure 2G). Importantly, the dermal P4-Figure 3. Coexpressed Genes among CD11b+ Dermal Cell Subsets
(A) Groups of genes coexpressed amongCD11b+ dermal cell subsets and Ly-6Chi
as C1 to C6.
(B) Expression profiles of selected genes among the six identified CD11b+ derm
relative gene expression normalized to the maximal value observed in the analyze
condition. See also Figure S3 and Table S2.
IP5 macrophages also achieved a degree of chimerism similar
to that of the dermal P1-P3 cells. Therefore, based on parabiotic
mice, a substantial fraction of dermal macrophages found in the
dermis appeared to be continuously replenished from adult
blood-borne precursors.
Dermal CD11b+ DCs, moDCs, and Macrophages Have
Distinct Functions
To establish the functions of the moDCs, macrophages and
CD11b+ DCs found in the steady-state dermis, we further ex-
ploited ourmicroarray data. Definition of clusters of coexpressed
genes through the generation of self-organizing maps (SOM)
allowed the identification of more than a hundred genes that
were either preferentially expressed in one or shared between
some of the analyzed cell populations (Figure 3A; Table S2).
Individual expression profiles of representative genes from
each SOM cluster are provided in Figure 3B. CD11b+ dermal
DCs specifically expressed Adam23, Clec4g, and P2ry10 that
code for a disintegrin and metalloprotease, for a C-type lectin
and for a purinergic, G protein-coupled receptor, respectively.
Consistent with previous studies (Guilliams et al., 2010),
CD11b+ dermal DCs were the sole cells to express Aldh1a2,
that codes for aldehyde dehydrogenase and accounts for their
regulatory T cell-inducing capacity. As expected,Mertk was pri-
marily expressed in P4 andP5macrophages together with genes
such as C4b, Cd209f, Tlr5, Pdgfc, and Itga9. Stabilin-1, a scav-
enger receptor involved in the clearance of oxidized and acety-
lated low-density lipoprotein and of matricellular glycoproteins,
was specifically expressed by P4 and P5 macrophages. P4 and
P5 macrophages were also the only cells to express CD36, a
member of the class B scavenger receptor family. When
compared to the other populations analyzed, the P4 andP5mac-
rophages expressed particularly low amounts of Fn1 and Ltb4r1.
In contrast to CD11b+ DCs, the moDCs and macrophages found
in the steady-state dermis expressed substantial amounts of Il10.
CD11b+ DCs and P2 and P3 moDCs commonly expressed
Klrb1b andCd226 that codes for CD161, an inhibitory NK recep-
tor, and for a receptor involved in intercellular adhesion, respec-
tively. Itgax codes for CD11c and was expressed by P2-P3
moDCs and by CD11b+ DCs (Figure 2B). Consistent with cyto-
metric analysis (Table S1), CD11b+ DCs expressed, however,
higher amounts of Itgax than P2-P3 moDCs.
To compare the T cell stimulatory properties of the moDCs,
macrophages, and CD11b+ DCs found in steady-state dermis,
we used an in vitro antigen-presentation assay in which OT-I
CD8+ T cells, which express a T cell receptor (TCR) specific
for an ovalbumin (OVA) peptide corresponding to residues
257–264 presented by H-2Kb, were labeled with the division-
tracking dye Cell Trace Violet (CTV). MoDCs, macrophages,
and CD11b+ DCs were sorted from steady-state dermis and
pulsed with the OVA257–264 peptide and cultured together with
OT-I cells (Figure 4A). After 5 days of culture, the moDCs,bloodmonocytes were identified with self-organizedmaps (SOM) and denoted
al cell subsets and Ly-6Chi blood monocytes. The y axis corresponds to the
d samples. Data are shown as mean ± SD with three independent samples per
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Figure 4. Functions of the moDCs, Macrophages, and DCs
(A) MoDCs (P2 + P3), macrophages (P4 + P5), and CD11b+ DCs were sorted from steady-state dermis, pulsed with OVA or the OVA257–264 peptide, and cultured
together with CTV-labeled OT-I CD8+ and OT-II CD4+ T cells. After 5 days of culture, the extent of proliferation was determined by CTV-dilution, and IFN-g
production was assessed by intracellular staining.
(B) Quantification of the data shown in (A). The absolute number of divided cells and of IFN-g+ cells among divided cells are shown. Error bars correspond to the
mean ± SD.
(C) Phagocytic activity of theCD11b+ dermal cell subsetsmeasured by the uptakeof pHrodoRedE.ColiBioParticle conjugates.MeanDMFI corresponds to themean
fluorescence intensity (MFI)at37CminustheMFIat4C.Errorbarscorrespondto themean±SD.Data in (A)–(C)are representativeof three independentexperiments.
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Resolving Skin Mononuclear Phagocyte Complexitymacrophages, and CD11b+ DCs were all capable of inducing a
robust OT-I cell proliferation, and moDCs and DCs triggered
the production of higher amount of interferon-g (IFN-g) than
macrophages. In contrast, in parallel cultures in which the whole
OVA protein was used in lieu of OVA257–264, CD11b
+ DCs and, to
a lower extent, moDCs were the sole capable of cross-
presenting OVA and of inducing the proliferation and production
of IFN-g. When OT-II CD4+ T cells, which express a TCR specific
for an OVA peptide presented by H2-Ab, were used in place of
OT-I T cells, dermal CD11b+ DCs and, to a lower extent, moDCs,
were also the sole capable of inducing the proliferation and pro-
duction of IFN-g by OT-II cells (Figure 4A). Quantification of the
data (Figure 4B) confirmed that OVA-pulsed dermal macro-
phages were unable to trigger CD8+ and CD4+ T cell responses
despite their expression of MHCI and II molecules and of costi-
mulatory molecules in amount comparable to moDCs and
CD11b+ DCs (data not shown). Conversely, dermal macro-
phages had the highest phagocytic capacity as compared to
moDCs and CD11b+ DCs (Figure 4C). Therefore, transcriptomic
and functional data concurred to demonstrate the distinct func-
tional specialization of dermal CD11b+ DCs and macrophages in
that dermal CD11b+ DCs possessed the strongest capacity to
stimulate antigen-specific T cells in responses to whole, unpro-
cessed antigen, whereas dermal macrophages failed in that
task and excelled in scavenging and phagocytic activities.
Consistent with their expression of a transcriptomic signature
convergent with that of conventional DCs, dermal moDCs were
capable of stimulating naive T cells, however with a lower
efficiency than dermal CD11b+ DCs.
CHS Increases P1 and P2 Cell Numbers
During the sensitizing phase of CHS, epicutaneously applied
haptens such as 2,4-dinitro-1-fluorobenzene (DNFB) are
acquired and conveyed to draining LNs by both LCs and dermal
DCs, resulting in the priming of DNFB-specific naive CD4+ and
CD8+ T cells. In addition, during the early inflammatory response
following DNFB exposure, blood Ly-6Chi monocytes are re-
cruited to the inflamed skin but their relevance to the elicitation
of hapten-specific T cells remains unclear. By using our refined
classification of skin mononuclear phagocytes, we showed
that DNFB application on the ear triggered a rapid and massive
increase of dermal CD11b+ cells. P1 monocytes dominated this
infiltrate, whereas P2moDCs represented approximately 10%of
it (Figures 5A and 5B). Therefore, as in intestinal inflammation
(Bain et al., 2013; Tamoutounour et al., 2012), the extravasated
monocytes found in DNFB-treated dermis fail to differentiate
beyond the P2 stage, whereas in both healthy dermis and LP
they fully downregulate Ly-6C and reach the P3 stage (Figure 1;
Figure S1D). DNFB application had no major effect on the
absolute numbers of CD11b+ DCs and P4-P5 macrophages
found in the dermis. However, owing to the massive influx of
P1 cells, their relative representation decreased among dermal
CD11b+ cells (Figure 5B).
To assess the global impact of DNFB treatment on P1 mono-
cytes, P2 moDCs, and CD11b+ DCs, we determined their gene-
expression programs and compared them to those of their
steady-state counterparts. The smaller frequency of P3 moDCs
and P4-P5 macrophages found in the inflamed skin prevented
their analysis. Although DNFB treatment increased the expres-Ision of Fcgr1 (Cd64) and Mertk (Figure 5D), this was without
effect on our ability to distinguish monocytes, moDCs, macro-
phages, and DCs (Figure 5A). DNFB treatment profoundly
affected the gene-expression profile of dermal P1 monocytes,
P2 moDCs, and CD11b+ DCs. Venn diagrams showed that 497
genes were induced and 462 genes were inhibited in CD11b+
dermal DCs (Figure 5C). In addition, 155 and 254 genes were
induced and 89 and 252 genes were inhibited in P1 and P2 cells,
respectively. Therefore, DNFB treatment modified the CD11b+
DC signature to a larger extent than that of P1 monocytes and
P2 moDCs. Remarkably, upon DNFB treatment, more genes
were similarly modulated in P2 moDCs and CD11b+ DCs (234
genes) than in P1 monocytes and CD11b+ DCs (52 genes) and
even than in P1 and P2 cells that are both monocyte-derived
(72 genes). Therefore, the commonalities observed in the
steady-state between the P2-P3 moDCs and CD11b+ DC
gene-expression programs (Figures 2B and 3) extend to inflam-
matory responses. Some genes such as Ddx58, Ifit2, Irf8, Irf7,
Isg20, Mmp14, Oas2, and Oasl2 were specifically upregulated
by DNFB in all the analyzed dermal cell types. Interestingly,
most of them corresponded to IFN-stimulated genes that
contribute to transcriptional regulation (Irf7 in response to type
I IFN and Irf8 in response to IFN-g), to sense viral RNA (Ddx58)
and to mediate the antiviral effects of type I IFN (Ifit2, Oas2,
Oasl2). Therefore, during CHS sensitization, many type I IFN-
stimulated genes were induced in both monocyte-derived
P1-P2 cells and in CD11b+ DCs, suggesting that epicutaneous
DNFB application induced the local production of type I IFN.
Dermal moDCs Have a Poorer Migratory Ability than
CD11b+ Dermal DCs
The auricular LNs that drain the ear skin contain CD11cinter to hi
MHCIIhi cells that correspond to the migratory counterpart of
skin DCs (Henri et al., 2010). Among the skin-derived CD11b+
cells found in steady-state auricular LNs, 95% were Ly-
6C–CD64– (Figure 6A) and their presence was independent of
CCR2 expression (data not shown), as expected for dermal-
derived CD11b+ DCs. The remaining 5% merged into the Ly-
6Clo to +CD64lo to hi gate and based on their CCR2-dependence
and CD64lo to +MerTK– phenotype likely corresponded to
dermal-derived moDCs (Figure 6A; data not shown). Therefore,
the skin-derived CD11b+ cells that reached the auricular LNs
under steady-state conditions were massively dominated by
CD11b+ dermal DCs (see also time point t0 in Figure 6B).
Increased numbers of migratory CD11b+ DCs and CD11b+
non-DCs reached the auricular LNs after DNFB application on
the ear (Figures 6A and 6B). Consistent with a dermal origin, after
epicutaneous application of a fluorescent dye (TRITC) and of
DNFB, the CD11b+ DCs found in the auricular LN were labeled
with TRITC (Figure 6C). Five lines of evidence suggested that
the migratory CD11b+ non-DCs corresponded to migratory
dermal moDCs. First, 3 days after application of TRITC and
DNFB, they showed percentages of TRITC+ cells that were
even higher than those of migratory CD11b+ dermal DCs (Fig-
ure 6C), a feature likely related to their higher phagocytic activity
as compared to CD11b+ DCs (Figure 4C). Second, akin to
CD11b+ DCs, CD11b+ non-DCs were absent from the auricular
LNs of CCR7-deficient mice following epicutaneous application
of DNFB (Figure 6D), a finding consistent with the presence ofmmunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc. 933
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Figure 5. Response to DNFB-Mediated Skin Inflammation
(A) Mice were sensitized with DNFB and, 3 days after DNFB application, the dermal CD11b+ non-DC cells were analyzed as in Figure 1A. The percentages of cells
found in each of the specified gates are indicated.
(B) Pie chart representation of P1 monocytes, moDCs (P2-P3), macrophages (P4-P5), and CD11b+ DCs found in the dermis 3 days after DNFB application. The
pie chart corresponding to steady-state dermis is also shown. The surface of the pie charts is proportional to the absolute numbers of CD11b+ cells per ear. Data
in (A) and (B) are representative of three independent experiments.
(C) Venn diagrams showing the impact of DNFB-treatment on the gene-expression profile of P1 monocytes, P2 moDCs, and CD11b+ DCs found in the dermis
3 days after DNFB application. UP and DOWN correspond to genes up- and downregulated, respectively, as compared to steady-state conditions. The number
of unique genes found in each section of the Venn diagrams is indicated.
(D) Expression profiles of selected genes in P1 and P2 cells and in CD11b+ DCs prior to or 3 days after DNFB application. The y axis corresponds to the relative
gene expression normalized to the maximal value observed in the analyzed samples. Data are shown as mean ± SD with three independent samples per
condition. See also Figure S4 and Table S2.
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Resolving Skin Mononuclear Phagocyte Complexitylow amounts of Ccr7 transcripts in dermal moDCs (Figure 5D).
Third, those migratory CD11b+ non-DCs expressed the same
CD64lo to +MerTK– phenotype as dermal moDCs (data not934 Immunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc.shown). Fourth, their presence was dependent on CCR2 expres-
sion, a feature expected for the migratory counterpart of dermal
monocytes (Figure 6E). Fifth, migratory CD11b+ non-DCs
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Figure 6. Migratory and T Cell Stimulatory Properties of Dermal-Derived CD11b+ moDCs and CD11b+ DCs following DNFB Treatment
(A) Dermal-derived CD11b+ cells present in the auricular LN under steady-state conditions or 3 days after DNFB treatment were analyzed for Ly-6C and CD64
expression. The percentages of cells found in each of the specified gates are indicated.
(B) Kinetics of accumulation of skin-derived CD11b+ DCs and CD11b+ non-DCs in the auricular LNs after DNFB application on the ear. The error bars correspond
to mean ± SD.
(C) Percentages of TRITC+ cells found among skin-derived CD11b+ DCs and CD11b+ non-DCs found in the auricular LN 2 days after treating the ear with TRITC
and DNFB. The percentages of cells found in the TRITC+ gate is indicated.
(D) Absolute numbers of CD11b+ non-DCs found in the auricular LN of WT and Ccr7–/– mice 3 days after treating the ear with DNFB. Data in (A)–(D) are
representative of three independent experiments.
(E) The ears of B6 (CD45.1) WT + B6 (CD45.2)Ccr2–/–/ B6 (CD45.1-CD45.2) chimeras were treated with DNFB and the auricular LNs were analyzed 3 days after
sensitization. The CD45.1 (WT)/CD45.2 (Ccr2–/–) ratio found among CD11b+ dermal DCs and CD11b+ non-DCs was determined. Each dot corresponds to a
mouse and the mean (horizontal bar) is indicated.
(F) Dermal-derived moDCs and CD11b+ DCs were sorted from the auricular LN 3 days after treating the ear with DNFB and cultured with CD8+ T cells and CD4+
T cells isolated from DNFB-sensitized mice. The absolute numbers of IFN-g+ cells found among CD8+ and CD4+ T cells were determined after 3 days of culture.
Data are representative of three independent experiments, and error bars correspond to the mean ± SD. See also Figure S5.
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Resolving Skin Mononuclear Phagocyte Complexityexpressed high amounts of genes selectively expressed by P2
or P3 dermal moDCs as compared to P4 and P5 dermal
macrophages and conversely lacked expression of the P4-P5
transcriptomic fingerprint (Figures S4A, S4C, and S4D).
Dermal moDCs were thus capable of migrating in a CCR7-
dependent manner to the auricular LNs following DNFB-
induced skin inflammation. They however constituted a minorIfraction of the dermal-derived CD11b+ migratory cells
found in the auricular LN (Figure 6B). Therefore, in both
steady-state and inflammatory conditions, CD11b+ dermal
DCs showed superior migratory ability as compared to dermal
moDCs. Importantly, dermal macrophages were unable to
migrate under both steady-state and DNFB-induced inflamma-
tory conditions.mmunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc. 935
Immunity
Resolving Skin Mononuclear Phagocyte ComplexityMigratory moDCs and CD11b+ DCs Show Convergent
Transcriptomic Signatures
Although the migratory CD11b+ DCs and moDCs found in the
auricular LNs of DNFB-treated ears originated from pre-DCs
and Ly-6Chi monocytes, respectively, their activation and migra-
tionwas accompanied by a striking convergence in gene expres-
sion. Indeed, several hundred of the genes specifically up- or
downregulated in migratory CD11b+ DCs as compared to their
CD11b+ dermal DC precursors underwent similar expression
changes in migratory moDCs as compared to their dermal pre-
cursors (Figure S4B, S4E, and S4F). This convergent gene
expression involved in particular the upregulation of many genes
involved in antigen processing and presentation and in crosstalk
with T lymphocytes (Figure S4E). Therefore, the few dermal
monocytes that migrated to the auricular LN upon DNFB treat-
ment were characterized by the acquisition of a gene-expression
program resembling that of migratory CD11b+ dermal DCs and
characteristic of professional antigen-presenting cells. This
raised the question of their specific contribution to the activation
of hapten-specific T lymphocytes during the sensitization phase
of CSH.
Migratory moDCs Have Reduced T Cell Stimulatory
Capacity
We assessed whether the dermal-derived CD11b+ DCs and
moDCs found in the auricular LNs 3 days after epicutaneous
DNFB application were able to activate DNFB-specific CD8+
and CD4+ T cells. Accordingly, dermal-derived CD11b+ DCs
and moDCs were sorted from the auricular LNs of DNFB-treated
mice and cocultured with CFSE-labeled CD8+ and CD4+ T cells
isolated from mice that had been sensitized for 5 days with
DNFB. After 3 days of culture, the absolute numbers of IFN-g-
producing CD8+ and CD4+ T cells were determined. Migratory
CD11b+ dermal DCs possessed the strongest capacity to induce
IFN-g production by DNFB-specific CD8+ and CD4+ T cells,
whereas migratory dermal moDCs induced 3.5-fold less IFN-g-
producing CD8+ T cells and almost no IFN-g-producing CD4+
T cells (Figure 6F). Therefore, the few dermal-derived moDCs
that reached the draining LNs following DNFB application had
on aper-cell basis a poor T cell stimulatory capacity as compared
to that of the quantitatively major CD11b+ dermal DCs. A model
recapitulating the findings of our study is shown in Figure S5.
DISCUSSION
Wehave shown that in healthy and inflameddermis, expression of
a small group of cell-surfacemarkers suffices to accurately distin-
guish CD11b+ DCs, dermal monocytes, moDCs, and
macrophages. On that basis, we revisited their origin and, as ex-
pected for conventional DCs, found that the CD11b+ dermal
DCs developed in a Flt3L-dependent and CCR2-independent
manner. We also delineated a previously unrecognized develop-
mental series that unfolds in noninflammatory conditions and
begins with extravasated Ly-6Chi blood monocytes to generate
dermal P2 and P3 cells that acquire transcriptomic features remi-
niscentofCD11b+DCson the topof theirmonocytic signatureand
were thus called moDCs. Adoptive transfer of Ly-6Chi blood
monocytes failed to yield enough donor-derived monocytes and
moDCs in steady-state ear dermis to reach statistical significance936 Immunity 39, 925–938, November 14, 2013 ª2013 Elsevier Inc.and directly establish whether they were linked by a precursor-
product relationship. However, unsupervised statistical tests
involving genome-wide transcriptome analysis allowed us to
establish that Ly-6Chi blood monocytes have a transcriptional
profile that links them to P1 dermal monocytes. Moreover,
analysisofdermis for thekineticsof reappearanceof theP1mono-
cytes and of the P2-P3 moDCs following diphtheria toxin (DT)
treatment of CD11b-DTR mice demonstrated a sequential P1/
P2/ P3 replenishment as observed in the LP of the intestine
(Bain et al., 2013; Tamoutounour et al., 2012). Note that thedermal
moDCs identified in the present study resemble the CD14+ non-
autofluorescent cells found in human skin (Haniffa et al., 2012) in
that they both display phenotypic and functional attributes that
are intermediate between the DC and macrophages.
In contrast to dermal moDCs that differentiate from ex-
travasated Ly-6Chi monocytes, the origin of the dermal P4-P5
macrophages appeared more complex. Although comparative
transcriptomic analysis aligns them with tissue-resident macro-
phages of primitive origin, competitive BM radiation chimeras
and parabiotic mice suggested that dermal macrophages can
also derive from adult blood-borne monocytes in a CCR2-
dependent manner. Full appreciation of the dermal macrophage
complexity will require lineage-tracing experiments (Hoeffel
et al., 2012; Schulz et al., 2012) to assess the exact contribution
of embryonic and adult hematopoiesis to the maintenance of the
pool of adult dermal macrophages and to establish its dynamics
following acute and chronic skin inflammations.
The breadth of our microarray data set and our functional
studies unraveled the functional specialization that separates
the CD11b+ DCs, moDCs, and macrophages found in the
dermis. For instance, the high phagocytic activity of P4-P5
dermal macrophages, as well as their expression of Stabilin-1
and CD36, highlighted their unique role in scavenging degrada-
tion intermediates of self-macromolecules and in killing
microbes. Consistent with an anti-inflammatory role, the moDCs
andmacrophages found in the steady-state dermis differed from
CD11b+ DCs in that they expressed Il10 transcripts. Considering
that the preservation of T cell epitopes requires limited degrada-
tion of proteins, the highly proteolytic nature of macrophage
lysosomes likely accounted for the inability of dermal P4-P5
macrophages to present OVA protein, as compared to dermal
DCs and moDCs. Dermal macrophages were unable to migrate
to cutaneous draining LNs under both steady-state and inflam-
matory conditions. In contrast, a small fraction of the moDCs
found in the dermis of DNFB-treated ears acquired a migratory
potential associated with a transcriptomic signature resembling
that of mature migratory CD11b+ DCs. Such convergence
allowed dermal-derived migratory moDCs to play a role, albeit
minor when compared to dermal-derived migratory CD11b+
DCs, in the elicitation of IFN-g-producing T cells. If we consider
the skin dermis and its corresponding draining LNs as a func-
tional anatomical unit, the bulk of moDCs are thus primarily
found in the dermis. It remains to be demonstrated whether
this positioning together with their T cell stimulatory capacity
make dermal moDCs particularly well suited to activate skin
tropic memory and regulatory T cells. The ability to migrate to
LNs under steady-state and inflammatory conditions and to
activate naive T cells remains thus a cardinal feature of pre-
DC-derived dermal DCs.
Immunity
Resolving Skin Mononuclear Phagocyte ComplexityIn conclusion, we have defined a gating strategy that is based
on the differential expression of a small set of surface markers.
This strategy allows the unequivocal identification of DCs,mono-
cytes, moDCs, and macrophages in the dermis of mice under
healthy and inflamed conditions. This gating strategy appears
to be general in that it also applied to the mononuclear phago-
cyte system of the intestine.We demonstrated that a high degree
of functional specialization occurs among the CD11b+ DCs, the
moDCs and the macrophages found in the dermis. Moreover,
our microarray analysis greatly expanded the number of candi-
dates for a role in DC biology. For instance, Zeb1 that codes
for a transcriptional repressor involved in epithelial-mesen-
chymal transition was found specifically upregulated during the
activation and migration of DCs and moDCs. Conversely, Eif4e
that aids in translation initiation was specifically repressed during
the activation of DCs andmoDCs.When combinedwith compar-
ative transcriptomic studies aiming at aligning DCs, moDCs, and
macrophages in mouse and human, our study should also facil-
itate the rational design of targeted immunotherapies and the
management of inflammatory skin diseases.EXPERIMENTAL PROCEDURES
Mice
Mice were housed under SPF conditions. GF mice were purchased from
TAAM. Ccr2–/– (Boring et al., 1997), Flt3l–/– (McKenna et al., 2000), CD11b-
DTR (Duffield et al., 2005), Ccr7–/– (Fo¨rster et al., 1999), OT-I (Hogquist et al.,
1994), and OT-II (Barnden et al., 1998) mice have been described. All mice
were maintained on a B6 background and handled in accordance with French
directives.
Isolation of DCs, Monocytes, and Macrophages from Skin and CLNs
DCs and other myeloid cell types were isolated from lymphoid and
nonlymphoid organs as previously described (Henri et al., 2010).
Flow Cytometry
Cells were stained and analyzed with a FACS LSRII system with Flowjo soft-
ware (Tree Star). Antibodies used are listed in Supplemental Experimental Pro-
cedures. Neutrophils and B, T, and NK cells were systematically gated out with
a Lin+ gate (see Figure S1A).
Generation of BM Chimera
Seven- to 8-week-old B6 CD45.1 3 CD45.2 mice or CD45.1 B6 mice were
lethally irradiated with two doses of 550 rads, 5 hr apart, and then injected
i.v. with 2 3 106 BM cells from femurs and tibias of WT B6 (CD45.1), Ccr2–/–
(CD45.2), or CD11b-DTR (CD45.2) mice.
Generation of Parabiotic Mice
Nine-week-old B6 CD45.1 mice were sutured together with 9-week-old B6
CD45.2 and subsequently kept under Bactrim for 8 to 10 weeks before
analysis.
Cell Sorting
For morphological, functional and microarray analyses, skin and LN cells were
sorted according to the marker combinations described in Table S1. For
microarrays cells were sorted directly in lysis buffer provided from the
QIAGEN RNA extraction kit.
Cell Morphology
Sorted dermal cell subsets were spun onto Super + glass microscope slides
with a Thermo Shandon Cytospin 4 cytofuge (4 min at 400 G). Cells were
then fixed with methanol and stained with Wright-Giemsa staining.IIn Vivo Cell Depletion
CD11b-DTR (CD45.2)/ B6 (CD45.1) BM chimeras were injected i.p. twice
and 48 hr apart with 1 mg of DT (Calbiochem, EMD Millipore).
Assessment of Phagocytosis
Cells were stained for cytometry, incubated for 15 min at 37 or 4C with
0.5 mg/ml of pHrodo E.Coli bioparticules (Life Technologies), washed, and
then analyzed by flow cytometry.
DNFB-Mediated Inflammation
Briefly, DNFB (Sigma-Aldrich) was diluted in acetone/olive oil (4:1), and 10 ml of
a 0.5% solution was applied to the dorsal side of the mouse ears. Ears and
auricular LN were harvested and analyzed by flow cytometry at different
time points after sensitization.
Preparation of T Cells and T Cell Stimulation
Preparation of T cells and T cell stimulation are described in Supplemental
Experimental Procedures.
RNA Isolation and Microarray Analysis
RNA isolation and microarray analysis are described in Supplemental Experi-
mental Procedures.
Statistical Analyses
The unpaired Student t test was used for statistical analyses with GraphPad
Prism software.
ACCESSION NUMBERS
The microarray data have been deposited in the Gene Expression
(GEO) database (http://www.ncbi.nlm.nih.gov/gds) under accession number
GSE49358.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.immuni.2013.10.004.
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